Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2006-06-26 - 2007-02-09
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conducted according to an internationally accepted guideline. All study parameters are based on the specific guideline.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2007
Report date:
2007

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Phenyl diamidophosphate
EC Number:
231-218-6
EC Name:
Phenyl diamidophosphate
Cas Number:
7450-69-3
Molecular formula:
C6H9N2O2P
IUPAC Name:
[(diaminophosphoryl)oxy]benzene
Test material form:
solid: crystalline
Details on test material:
Name of test substance: Phenyl diamidophosphate
CAS No.: 7450-69-3
Purity: 96.3 g/100 g

Test animals

Species:
rat
Strain:
Wistar
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: RCC Ltd Laboratory Animal Services, Wölferstrasse 4, CH-4414 Füllinsdorf, Switzerland
- Age at study initiation: Young adult animals (female animals approx. 8 – 12 weeks)
- Weight at study initiation: Animals of comparable weight (± 20% of the mean weight
- Fasting period before study: Feed was withdrawn from the animals at least 16 hours before
administration, but water was available ad libitum.
- Housing: The animals were housed in fully air-conditioned rooms.
Type of cage: Stainless steel wire mesh cages, type DK-III (Becker & Co., Castrop-Rauxel, FRG)
Number of animals per cage: Single housing
- Diet (e.g. ad libitum): Kliba-Labordiät (Maus / Ratte Haltung “GLP”), Provimi Kliba SA, Kaiseraugst, Basel, Switzerland, ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: Acclimatization for at least 5 days before administration.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 – 24°C
- Humidity (%):30 – 70%
- Air changes (per hr): fully air-conditioned
- Photoperiod (hrs dark / hrs light): 12 h / 12 h (6.00 a.m. – 6.00 p.m. / 6.00 p.m. – 6.00 a.m.)

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Doses:
2000 mg/kg in 3 females, 500 mg/kg in 3 females, 300 mg/kg in 6 females
No. of animals per sex per dose:
see above
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Body weight determination: Individual body weights shortly before administration (day 0), weekly thereafter and at the end of the study.
Signs and symptoms: Recording of signs and symptoms several times on the day of administration, at least once each workday for the individual
animals; these records are maintained with the raw data.
Mortality: A check for any dead or moribund animal was made twice each workday and once on Saturdays, Sundays and on public holidays.
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
> 300 - < 500 mg/kg bw
Based on:
test mat.
Mortality:
All animals of the 2000 mg/kg administration group and two animals of the 500 mg/kg adminstration group were found dead from hour 1 through to hour 2 after application. No mortality occurred in the 300 mg/kg administration groups.
Clinical signs:
Clinical observation in the administration groups revealed impaired and poor general state, dyspnoea, apathy, excitation, abdominal position, staggering, tremor, twitching, fibrillar contractions, clonic convulsions, piloerection, smeared fur, diarrhea, exsiccosis, salivation, lacrimation, chromodacryorrhea and reduced feces. Findings were observed from hour 1 through to study day 5 after administration.
Body weight:
The mean body weights of the 300 mg/kg administration groups and the body weight of the surviving animal of the 500 mg/kg group increased throughout the study period.
Gross pathology:
No macroscopic pathologic abnormalities were noted in the animals that died (2000 mg/kg: 3 females; 500 mg/kg: 2 females) and in the animals examined at termination of the study (500 mg/kg: 1 female; 300 mg/kg: 6 females).

Applicant's summary and conclusion

Interpretation of results:
Toxicity Category IV
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Under the conditions of this study the median lethal dose of Phenyl diamidophosphate after oral administration was found to be greater than 300 mg/kg and less than 500 mg/kg body weight in rats.
Executive summary:

The study was performed according to OECD Guideline 423 to assess the acute toxicity following oral administration of Phenyl diamidophosphate in Wistar rats. Single doses of 2000, 500 and 300 mg/kg body weight of test material preparations in olive oil Ph.Eur./DAB were given to 4 administration groups of three fasted female animals each, (2000 mg/kg in 3 females, 500 mg/kg in 3 females, 300 mg/kg in 6 females) by gavage in a sequential manner. All animals of the 2000 mg/kg administration group and two animals of the 500 mg/kg adminstration group were found dead from hour 1 through to hour 2 after application. No mortality occurred in the 300 mg/kg administration groups. Clinical observation in the administration groups revealed impaired and poor general state, dyspnoea, apathy, excitation, abdominal position, staggering, tremor, twitching, fibrillar contractions, clonic convulsions, piloerection, smeared fur, diarrhea, exsiccosis, salivation, lacrimation, chromodacryorrhea and reduced feces. Findings were observed from hour 1 through to study day 5 after administration. The mean body weights of the 300 mg/kg administration groups and the body weight of the surviving animal of the 500 mg/kg group increased throughout the study period. No macroscopic pathologic abnormalities were noted in the animals that died and in the animals examined at the end of the observation period. Under the conditions of this study the median lethal dose of Phenyl diamidophosphate after oral administration was found to be greater than 300 mg/kg and less than 500 mg/kg body weight in rats.